These results suggested that both PSCA and Oct-4 are highly expressed in gallbladder adenocarcinoma, and they could be regarded as molecular markers to evaluate the malignant transformation of GBC. This evidence concerns the gene POU5F1 and gallbladder adenocarcinoma.